Applied DNA Sciences (NASDAQ:APDN) announced its earnings results on Thursday. The technology company reported ($2.63) earnings per share for the quarter, missing analysts’ consensus estimates of ($1.26) by ($1.37), Fidelity Earnings reports. Applied DNA Sciences had a negative net margin of 221.66% and a negative return on equity of 1,284.19%. The company had revenue of $1.70 million for the quarter.
APDN opened at $4.26 on Friday. The firm has a 50 day moving average price of $4.09 and a 200-day moving average price of $1.31. Applied DNA Sciences has a twelve month low of $3.70 and a twelve month high of $45.20.
In related news, insider William W. Montgomery acquired 75,000 shares of the firm’s stock in a transaction dated Wednesday, November 13th. The stock was purchased at an average cost of $5.24 per share, with a total value of $393,000.00. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 22.42% of the stock is owned by insiders.
Applied DNA Sciences Company Profile
Applied DNA Sciences, Inc develops and markets plat based or other DNA technology solution in the United States, Europe, and Asia. The company's supply chain security and product authentication solutions include SigNature molecular tags that are ingredients used to fortify brand protection efforts and strengthen supply chain security, as well as mark, track, and convict criminals; SigNature T molecular tags, which are tagging and authentication systems for use in brand protection efforts and raw material source compliance programs; and fiberTyping, a test of native cotton fiber DNA.
Featured Story: What Factors Can Affect Return on Equity?
Receive News & Ratings for Applied DNA Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied DNA Sciences and related companies with MarketBeat.com's FREE daily email newsletter.